Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00417261
Status:
COMPLETED
Last Update Posted:
2008-06-23
First Post:
2006-12-28
Brief Title:
Safety Tolerability Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Active Comparator Ascending Single and Multiple Dose Seamless Design Study to Explore the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Two Orally Administered Compounds ATF936 and AXT914 in Healthy Male and Female Subjects
Status:
COMPLETED
Status Verified Date:
2008-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a first-in-human study and is designed to evaluate the safety tolerability pharmacodynamic and pharmacokinetic effects of a single and multiple-doses of ATF936 and AXT914 administered orally in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None